drugset / Trial / NCT04871347
The Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a multi-center, phase Ia/Ib, open clinical study to evaluate the safety and efficacy of TWP-101 in patients with advanced solid tumor. This study consists of two parts (Part A and Part B). Part A was a dose escalation study, and Part B was a dose expansion study.
Timeline
- Start
- 2021-08-30
- Primary completion
- 2023-06-30
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TWP-101 | Unknown | — | Intravenous |